The US v. Heppner ruling is not an edge case. It is a warning that using ChatGPT, Claude or any consumer AI tool for legal work in a UK regulated firm is now a compliance violation waiting to happen. The FCA Consumer Duty, SRA Code and ICO UK GDPR demand better.
Regulatory Watch  Trovix BriefLegal · Financial Services · Insurance

Yesterday's US federal court ruling in United States v. Heppner is not American news for UK lawyers to file away. It is a direct threat to every UK law firm, in-house legal team, insurer and accountancy practice that has ever typed a client matter into Claude, ChatGPT or any consumer AI tool. The court found that because Anthropic collects training data from prompts and may share it with third parties—including government bodies—attorney-client privilege and work-product protection simply do not exist. No confidentiality shield. No privilege log. No protection. The implications for UK regulated firms are stark: using consumer AI for legal work is now not just risky; it is a breach of your SRA Code of Conduct, FCA Consumer Duty obligations (PS22/9), and ICO UK GDPR responsibilities. Your client files, privileged instructions and confidential communications are no longer yours to claim as confidential.

This ruling exposes the fault line that has always existed in the AI-for-law industry: the difference between a consumer product and a regulated tool. Over the past 18 months, the market has flooded with generalist AI assistants pitched to legal professionals—Harvey, Legora, Luminance and dozens of others—each claiming to be 'the AI lawyer'. Most are built on top of consumer-grade models with consumer-grade data practices. The Heppner judgment pulls back the curtain: when you train an AI on billions of internet tokens and configure it to improve its model by learning from user input, you have built a system that cannot hold a secret. Regulators on both sides of the Atlantic are now waking up to this too. The EU AI Act's classification of legal AI as 'high-risk' is not bureaucratic caution; it is recognition that AI in law is not a productivity toy. It is a fiduciary obligation. UK firms that have been using ChatGPT for privilege work are now exposed to regulatory investigation, client complaints and malpractice liability. The pretence that 'just turning off data training' makes consumer AI safe for legal work is over.

Trovix's answer to this problem is structural, not rhetorical. We do not wrap consumer models in a legal skin and pretend that solves the confidentiality problem. Instead, Trovix uses enterprise-grade models deployed on isolated, UK-hosted infrastructure with no outbound data flows, no model training on your prompts, and no third-party access. More important: we build knowledge assistants and document automation tools that stay within the boundary of data you own and control. Trovix Aria runs on your data, not on the internet. Trovix Sift extracts and classifies documents without sending them through a black box. When you use Trovix, privilege stays privilege because your data never leaves your infrastructure and never trains anyone else's model. This is not marketing positioning. This is the only honest way to meet SRA Code 2024, FCA Consumer Duty, and ICO UK GDPR in legal and regulated work.

If you run a mid-market law firm, in-house legal team, insurance panel or accountancy practice: audit your AI use this week. If any team member has used a consumer AI tool—ChatGPT, Claude, Copilot—for client work, confidential advice, or file review in the past 12 months, you have a compliance exposure. Stop it today. Notify your information security and compliance teams. Review your AI policy and enforce it. Then implement an enterprise AI platform built for regulated work, not consumer convenience. The cost of a proper enterprise AI deployment is a fraction of the cost of a regulatory investigation, client claim or privilege waiver. Heppner is not a US-only problem. It is a warning that the legal profession got the AI question wrong and is now paying the price.

Source: Forbes

Related Trovix product:

Trovix Brief →Book a demo →